Biotinylated AntiSARSCoV2 Spike RBD Neutralizing Antibody, Human IgG1 (AM122) (S1NVM226) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARSCoV2 Spike S1 Protein. As verified in competitive ELISAbased and pseudovirusbased neutralization assay, this chimeric monoclonal can potently neutralize all SARSCoV2 Variants of Concern (VOCs), including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2). - Antikörper
Tag:
Mouse IgG1 & Avi | Mouse Kappa
Buffer:
PBS, pH7.4
Purity:
0.95
Form:
Powder
Target:
Spike RBD
S1N-VM226-25ug
Immobilized SARS-CoV-2 Spike RBD, His Tag (Cat. No. SPD-C52H3) at 2 µg/mL (100 µL/well) can bind Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AM122) (Cat. No. S1N-VM226) with a linear range of 0.2-13 ng/mL (QC tested).
Immobilized SARS-CoV-2 Spike Protein, His Tag, Super stable trimer (Cat. No. SPN-C52H9) at 2 µg/mL (100 µL/well) can bind Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AM122) (Cat. No. S1N-VM226) with a linear range of 0.2-13 ng/mL (Routinely tested)
Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AM122) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.
* VAT and and shipping costs not included. Errors and price changes excepted
